Perlman S - Search Results

1

Automated classification of benign and malignant lesions in ¹⁸F-NaF PET/CT images using machine learning.

Perk T, Bradshaw T, Chen S, Im HJ, Cho S, Perlman S, Liu G, Jeraj R. Perk T, et al. Among authors: perlman s. Phys Med Biol. 2018 Nov 20;63(22):225019. doi: 10.1088/1361-6560/aaebd0. Phys Med Biol. 2018. PMID: 30457118

2

Influence of reconstruction iterations on 18F-FDG PET/CT standardized uptake values.

Jaskowiak CJ, Bianco JA, Perlman SB, Fine JP. Jaskowiak CJ, et al. J Nucl Med. 2005 Mar;46(3):424-8. J Nucl Med. 2005. PMID: 15750154 Free article.

3

The impact of hybrid PET-CT scan on overall oncologic management, with a focus on radiotherapy planning: a prospective, blinded study.

Kruser TJ, Bradley KA, Bentzen SM, Anderson BM, Gondi V, Khuntia D, Perlman SB, Tome WA, Chappell RJ, Walker WL, Mehta MP. Kruser TJ, et al. Technol Cancer Res Treat. 2009 Apr;8(2):149-58. doi: 10.1177/153303460900800208. Technol Cancer Res Treat. 2009. PMID: 19334796 Free article. Clinical Trial.

4

PET/CT in the evaluation of inflammatory bowel disease: studies in patients before and after treatment.

Spier BJ, Perlman SB, Jaskowiak CJ, Reichelderfer M. Spier BJ, et al. Mol Imaging Biol. 2010 Jan-Feb;12(1):85-8. doi: 10.1007/s11307-009-0232-1. Epub 2009 May 9. Mol Imaging Biol. 2010. PMID: 19430844

5

Integrated PET/CT fusion imaging and endoscopic ultrasound in the pre-operative staging and evaluation of esophageal cancer.

Walker AJ, Spier BJ, Perlman SB, Stangl JR, Frick TJ, Gopal DV, Lindstrom MJ, Weigel TL, Pfau PR. Walker AJ, et al. Mol Imaging Biol. 2011 Feb;13(1):166-71. doi: 10.1007/s11307-010-0306-0. Mol Imaging Biol. 2011. PMID: 20379789

6

Clinical molecular imaging with PET agents other than 18F-FDG.

Hall LT, Struck AF, Perlman SB. Hall LT, et al. Curr Pharm Biotechnol. 2010 Sep 1;11(6):545-54. doi: 10.2174/138920110792246537. Curr Pharm Biotechnol. 2010. PMID: 20420567 Review.

7

A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC).

Harrison MR, Hahn NM, Pili R, Oh WK, Hammers H, Sweeney C, Kim K, Perlman S, Arnott J, Sidor C, Wilding G, Liu G. Harrison MR, et al. Among authors: perlman s. Invest New Drugs. 2011 Dec;29(6):1465-74. doi: 10.1007/s10637-010-9455-x. Epub 2010 May 25. Invest New Drugs. 2011. PMID: 20499131 Free PMC article. Clinical Trial.

8

Clinical utility of positron emission tomography/computed tomography in inflammatory bowel disease.

Lapp RT, Spier BJ, Perlman SB, Jaskowiak CJ, Reichelderfer M. Lapp RT, et al. Mol Imaging Biol. 2011 Jun;13(3):573-576. doi: 10.1007/s11307-010-0367-0. Mol Imaging Biol. 2011. PMID: 20574849 Clinical Trial.

9

Early assessment of treatment response in patients with AML using [(18)F]FLT PET imaging.

Vanderhoek M, Juckett MB, Perlman SB, Nickles RJ, Jeraj R. Vanderhoek M, et al. Leuk Res. 2011 Mar;35(3):310-6. doi: 10.1016/j.leukres.2010.06.010. Epub 2010 Sep 15. Leuk Res. 2011. PMID: 20832860 Free PMC article.

10

Pharmacodynamic study using FLT PET/CT in patients with renal cell cancer and other solid malignancies treated with sunitinib malate.

Liu G, Jeraj R, Vanderhoek M, Perlman S, Kolesar J, Harrison M, Simoncic U, Eickhoff J, Carmichael L, Chao B, Marnocha R, Ivy P, Wilding G. Liu G, et al. Among authors: perlman s. Clin Cancer Res. 2011 Dec 15;17(24):7634-44. doi: 10.1158/1078-0432.CCR-11-1677. Epub 2011 Oct 28. Clin Cancer Res. 2011. PMID: 22038997 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,272 results

Search Page

Filters